Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease

Background Chronic graft-versus-host disease is a common late complication of allogeneic hematopoietic stem cell transplantation. Corticosteroids are the standard initial treatment. Second-line treatment has not been well defined. We evaluated the effectiveness and safety of low doses of alemtuzumab...

Full description

Bibliographic Details

Main Authors:	Gutiérrez Aguirre, César Homero, Cantú Rodríguez, Olga Graciela, Borjas Almaguer, Omar David, González Llano, Óscar, Jaime Pérez, José Carlos, Solano Genesta, M., Gómez Guijosa, Miguel Ángel, Mancías Guerra, Consuelo, Tarín Arzaga, Luz del Carmen, Gómez Almaguer, David
Format:	Article
Language:	English
Published:	2012
Online Access:	http://eprints.uanl.mx/15027/1/627.pdf